Application of subclinical dosage of esketamine in fiberbronchoscopy in elderly patients: a randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053528

Enrollment

Unknown

Registered

2021-11-24

Start date

2021-11-25

Completion date

Unknown

Last updated

2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Using ethane ketamine and fentanyi for anesthesia induction

Group 2:Use the same amount of saline brine and fennia to induce anesthesia

Eligibility

Sex/Gender

All

Age

65 Years to 85 Years

Inclusion criteria

Inclusion criteria: Elderly patients who were scheduled to undergo painless fiberoptic bronchoscopy under general anesthesia with laryngeal mask, aged 65-85 years, body mass index 18-25 kg/m^2, and ASA I-III class.

Exclusion criteria

Exclusion criteria: 1. Patients with poor understanding, mental disorders or central nervous system disorders who cannot cooperate; 2. Potential or definite difficult airway, cardiovascular disease such as unstable angina, uncontrolled hypertension, high-risk coronary artery disease, history of heart disease; 3. Serious insufficiency of liver and kidney function; 4. Those with allergies and contraindications to the test drugs.

Design outcomes

Primary

Measure	Time frame
Depression score;Incidence of postoperative cognitive dysfunction;Quality of postoperative recovery;	—

Countries

China

Contacts

Public ContactChen Hanwen

53918749@qq.com+86 13724671233

Outcome results